Painchek Ltd · ASX:PCK
Painchek — Shareholder Meeting (November 2019)
13 slides from Painchek's shareholder meeting presentation, Nov 20, 2019
Slide 1: AGM – 20th November 2019
® For personal use only Philip Daffas CEO & MD AGM – 20th November 2019 PainChek Ltd ASX:PCK 1 PainChek™ Commercial in Confidence
Slide 2: PainChek 2019 Highlights
PainChek® 2019 Highlights ▪ Accelerating SaaS sales and proven business model in Australia in Residential Aged Care For personal use only • Numerous case studies published & positive clinical outcomes reported • Zero churn rate ▪ $5M Federal Government grant provides one-year universal access to all
Slide 3: The problem
The problem For personal use only Pain assessment is difficult especially for those who cannot communicate such as dementia sufferers or infants/toddlers. Pain is often under detected. Leading to under treatment and misdiagnosis. This can lead to adverse impact on quality of care, operational effici
Slide 4: Our “Why”
Our “Why” Our purpose is to For personal use only give a voice to people who cannot verbalise their pain 4 PainChek™ Commercial in Confidence
Slide 5: Pain assessment in dementia care is ready for disruption
Pain assessment in dementia care is ready for disruption Abbey Pain PainChek® Abbey Pain Scale (APS) and similar manual systems are the current For personal use only ▪ Scale 2017 standard of care in developed countries for assessment of pain in 2003 dementia patients ▪ Key inputs in the APS rely on
Slide 6: Australian Federal Government Support of $5m
Australian Federal Government Support of $5m • Aus Federal govt. has pledged $5m for PainChek to implement into Aus residential aged care market For personal use only • Government is paying for a 12 month subscription for up to 100k dementia beds • Govt wants to aid rapid adoption of PainChek and th
Slide 7: PainChek accelerating growth in clients, bed licenses and clinical assessments
PainChek® accelerating growth in clients, bed licenses and clinical assessments Contracted number of Residential Contracted Annual Recurring Revenue For personal use only Residential Aged Care Clients and Aged Care Beds (CNRB) (ARR) (A$m) Facilities Contracted 280 25000 24,170 Millions 1.02 * 1 250
Slide 8: Diversified customer and partners
Diversified customer and partners For personal use only Example Aged Care Customers Advocates & Supporters 8 PainChek™ Commercial in Confidence
Slide 9: Integration partners
Integration partners • We are integrated with most of the major aged care management systems used by more than 160,000 aged care beds For personal use only in Australia and 50,000 beds in the UK • Direct integration means data flows automatically into existing systems reducing duplication of data en
Slide 10: Update on Projected Product Launch Dates
Update on Projected Product Launch Dates ▪ Initial Market entry with Enterprise versions to validate utility with Health Care Professionals (HCP) sector and build value For personal use only ▪ Direct to Carer (DTC) market expansion when HCP support in place and DTC training materials Product Type Au
Slide 11: The Team
THE TEAM For personal use only Philip Daffas Prof. Jeff Hughes Mustafa Atee CEO & Managing Director, MBA, BSc Chief Scientific Officer PhD, MPS Research Scientist MPS, PhD (candidate) Philip is a highly accomplished global business Jeff is a professor in the School of Pharmacy, Mustafa is a clinical
Slide 12: The Board
THE BOARD For personal use only John Murray Chairman John Murray Philip Daffas Ross Harricks Adam Davey Non- Exec Chair CEO & Managing Director Non-Exec Director Non-Exec Director 25 years in tech and Venture Capital. Philip is a highly accomplished global Senior global medical device Corporate fina
Slide 13: AGM – 20th November 2019
® For personal use only Philip Daffas CEO & MD AGM – 20th November 2019 PainChek Ltd ASX:PCK 13 PainChek™ Commercial in Confidence